Department of Neurosurgery, Kyorin University Faculty of Medicine
Tokyo, Japan
Motoo Nagane, M.D., Ph.D.
Medical institution: Department of Neurosurgery, Kyorin University Faculty of Medicine, Kyorin University Hospital
Education:
Faculty of Medicine, The University of Tokyo, Tokyo. M.D./1984
The Japan Neurosurgical Society, Board Certified Neurosurgeon/1990
University of Tokyo, Tokyo. Degree of Medical Science (Ph.D.)/1994
Certificate of General Clinical Oncologist/2008, by Japanese Board of Cancer Therapy.
Research and Professional Experience:
6/1984-6/1985 Resident in Department of Neurosurgery, University of Tokyo Hospital, Tokyo, Japan
6/1985-12/1987 Medical staff in Neurosurgery, Kameda General Hospital, Chiba, Japan
1/1988-1/1991 Medical staff in Department of Neurosurgery, Emergency and Critical Care Medicine, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan
2/1991-2/1995 Medical staff in Department of Neurosurgery, National Cancer Center Hospital, Tokyo, Japan
3/1995-1/2000 Postdoctoral research fellow: investigation of the tumorigenesis of a mutant epidermal growth factor receptor (de 2-7 EGFR) in gliomas at the Ludwig Institute for Cancer Research in San Diego
2/2000-3/2005 Assistant professor, Department of Neurosurgery, Kyorin University School of Medicine, Tokyo, Japan
4/2005-10/2007 Associate professor, Department of Neurosurgery, Kyorin University School of Medicine, Tokyo, Japan
11/2007-3/2012 Associate professor, Department of Neurosurgery, Kyorin University Faculty of Medicine, Tokyo, Japan
4/2012-present Professor, Department of Neurosurgery, Kyorin University Faculty of Medicine, Tokyo, Japan
Editorial Board:
6/2006 Neuro-Oncology (to 2011)
2/2007 Asian Pacific Journal of Clinical Oncology (APJCO)
5/2007 Progress in Computed Imaging
4/2009 Neurologia medico-chirurgica
2/2010 International Journal of Clinical Oncology
9/2011 Japanese Journal of Clinical Oncology
10/2012 BRAIN and NERVE
5/2013 Brain Tumor Pathology（Associate Editor）
2/2014 Japanese Journal of Clinical Oncology (Associate Editor)
11/2015 Neuro-Oncology
4/2021 Neuro-Oncology (Associate Editor)
1/2022 Neuro-Oncology Practice
Specialized areas:
Malignant brain tumor, glioma, primary central nervous system lymphoma, chemotherapy, drug resistance, molecular biology, genetics
